Innovative gene therapy for autosomal dominant retinitis pigmentosa

by DBGen Ocular Genomics

Mutations in the RHO gene are the main cause of dominant forms of retinitis pigmentosa (RP). RHO dictates the production of rhodopsin, a transmembrane protein present in large quantities in the outer ...

Read more

Novel high-precision gene therapy to correct an eye disease in mice

by DBGen Ocular Genomics

Researchers from the Seoul National University (Korea) have applied for the first an improved genome-editing methodology, named prime editing to correct the genetic defects of two animal models of hum...

Read more

Encouraging advances in therapies for Leber congenital amaurosis

by DBGen Ocular Genomics

Editas Medicine, a company specialising in the development of gene editing therapies, has announced the recruitment of paediatric patients to the Brilliance trial.

Read more

Advanced gene therapy prevents 12-year-old girl from going blind

by Fundació Sant Joan de Déu

The SJD-Hospital Bellvitge Hereditary Retinal Dystrophy Unit has applied Novartis' Luxturna therapy to Noa, who only retained 3% of her vision.

Read more

Avoiding Costly IP Missteps: Insights for high-quality due diligence searches

by CAS, a division of the American Chemical Society

As chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...

Read more

Sartorius Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing

by Sartorius Stedim Spain

The life science company Sartorius signed a strategic collaboration with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media a...

Read more

A CNIO study links severe COVID-19 disease to short telomeres

by CNIO - Centro Nacional de Investigaciones Oncológicas

Patients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) in collaboration with th...

Read more

Christopher Mann – New Scientific and Regulatory Affairs Director

by Asphalion

Asphalion’s Board of Directors is pleased to announce the appointment of Christopher Mann as new Scientific and Regulatory Affairs Director.

Read more

Sartorius acquires filtration expert WaterSep BioSeparations

by Sartorius Stedim Spain

The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.

Read more

We interview Sara Secall, Inveready’s Director of Investments in Life Sciences

by GENESIS Biomed

Sara Secall, a chemistry graduate with a master’s degree in environmental science and an MBA, is the current partner and director of investments in Life Sciences at Inveready, a Venture Capital (VC)...

Read more

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS (Barcelona) secures a 1.5 million-euro investment from Invivo Ventures

by Invivo Capital

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological malignancies. The company raised

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...


Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New advances in cancer viral immunothera...

by Universitat de Barcelona

It has been developed a new strain of vaccinia virus, which can replic...

Photos Stream